Myostatin-inhibiting compound often grouped with SARMs — closer to a steroid in profile.
Typical dose range: 5–10 mg
Frequency: Daily
Route: Oral
Half-life: Hours
Evidence level: Pre-clinical
Anecdotally hepatotoxic and suppressive — keep cycles short and run liver support.